Literature DB >> 15660798

Electrocardiographic characteristics of fasciculoventricular pathways.

Seil Oh1, Yun-Shik Choi, Eue-Keun Choi, Hyo-Soo Kim, Dae-Won Sohn, Byung-Hee Oh, Myoung-Mook Lee, Young-Bae Park.   

Abstract

INTRODUCTION: Fasciculoventricular (FV) pathways are rare variants of preexcitation, and their ECGs may be misinterpreted as Wolff-Parkinson-White syndrome with anteroseptal accessory pathways (WPW-AS). We analyzed the electrocardiographic characteristics of the patients with FV pathways to find out the different findings from WPW-AS. METHODS AND
RESULTS: Five patients with FV pathways and four patients with WPW-AS who underwent electrophysiologic studies were evaluated. Intervals and amplitudes of each wave and QRS morphologies were analyzed in standard 12-lead ECGs of these patients by two independent cardiologists without the information of the electrophysiologic findings. PR intervals were longer in FV pathways (122 +/- 11.0 vs 83 +/- 21 ms, FV pathways vs WPW-AS, P = 0.017). In lead V1, narrower width of R waves (25 +/- 6 vs 45 +/- 13 ms, P = 0.037) and smaller amplitude of S waves (12.8 +/- 8.3 vs 26.6 +/- 7.4 mm, P = 0.037) were observed in FV pathways. The polarity of delta waves in V1 was flat or negative in contrast with the cases of WPW-AS in which the polarity was positive. Three of five patients had notching in the descending limb of S waves in V1, which was not observed in WPW-AS.
CONCLUSION: FV pathways have different ECG characteristics from WPW-AS in PR interval and morphology of QRS complexes in lead V1 of the standard 12-lead ECG.

Entities:  

Mesh:

Year:  2005        PMID: 15660798     DOI: 10.1111/j.1540-8159.2005.09371.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  1 in total

1.  Fasciculoventricular pathways-A rare and innocent variant: A Retrospective study focusing on clinical and electrophysiologic characteristics.

Authors:  Suat Gormel; Salim Yasar
Journal:  Ann Noninvasive Electrocardiol       Date:  2022-01-02       Impact factor: 1.485

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.